Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Lenalidomide
Related studies linked through entity extraction aliases.
Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Rituximab With or Without Lenalidomide in Treating Patients With Previously Untreated Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide in Kaposi Disease Associated With HIV Infection
- Status
- TERMINATED
- Phase
- PHASE2
Lenalidomide in HTLV-1 Adult T-Cell Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents
- Status
- COMPLETED
- Phase
- PHASE2
Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Everolimus (RAD001) in Combination With Lenalidomide
- Status
- COMPLETED
- Phase
- PHASE1